| Parameter | SNDK XS3334497495 |
MU XS3334497651 |
NBIS XS3218808510 |
NBIS² XS3302504371 |
IREN XS3334497818 |
|---|---|---|---|---|---|
| Rank | #4 | #2 | #3 | #1 BEST | #5 |
| Type | Outperf Bonus 200% | Outperf Bonus 200% | Outperf Bonus 150% | Booster 200% | Outperf Bonus 200% |
| Participation | 200% up / 100% dn | 200% up / 100% dn | 150% up / 100% dn | 200% up / 100% dn | 200% up / 100% dn |
| Entry / Strike | $1,290 | $609 | $81 | $110 | $50 |
| Ref Price (today) | $1,575 | $920 | $200 | $200 | $41 |
| Above Entry | +22% | +51% | +147% | +82% | −18% |
| Maturity | 12 May 2027 | 12 May 2027 | 29 Dec 2026 | 28 Jun 2027 | 12 May 2027 |
| Max Redemption (Cap) | 246% | 192% | 254% | 220% | 213% |
| Cap Trigger (underlying) | $2,232 (+42%) | $889 (AT CAP) | $164 (AT CAP) | $176 (AT CAP) | $78 (+90%) |
| Can buy now at | 125.00% | 133.00% | 195.00% | 120.00% | 80.00% |
| Value at expiry (current spot) | 144% | 192%CAP | 254%CAP | 220%CAP | 82% |
| Profit at maturity (%) | +15% | +45% | +30% | +83% | +2% |
| Profit at maturity (% p.a.) | +18% p.a. | +53% p.a. | +63% p.a. | +86% p.a. | +3% p.a. |
| Discount to Fair Value | +19.2pp | +59.3pp | +58.8pp | +100.2pp | +2.0pp |
| Breakeven (from ref) | $1,451 (−8%) | $709 (−23%) | $132 (−34%) | $121 (−39%) | $40 (−2%) |
| Issuer | Marex Financial (BBB/S&P) | Marex Financial (BBB/S&P) | Marex Financial (BBB/S&P) | Morgan Stanley (A+/S&P) | Marex Financial (BBB/S&P) |
| Analyst | Firm | Target | Rating |
|---|---|---|---|
| D. Holt | HC Wainwright | $28 › upd | BUY |
| Research | Canaccord | upd | BUY |
| Research | Roth MKM | upd | BUY |
| Analyst | Firm | Target | Rating |
|---|---|---|---|
| Harlan Sur | JPMorgan | upd | BUY |
| Joseph Moore | Morgan Stanley | upd | OW |
| Vijay Rakesh | Mizuho | upd | BUY |
| C.J. Muse | Evercore ISI | upd | OW |
| Analyst | Firm | Target | Rating |
|---|---|---|---|
| Research | Wells Fargo | upd | OW |
| Research | Bank of America | upd | BUY |
| Research | UBS | upd | NEUTRAL |
| Analyst | Firm | Target | Rating |
|---|---|---|---|
| Research | Citi | $287 | BUY |
| Research | Morgan Stanley | $144 | EW |
| Research | DA Davidson | $250 | NEUTRAL |